Slingshot members are tracking this event:
Phase 3 STYLE Study of Celgene's (CELG) OTEZLA (apremilast) in Moderate to Severe Scalp Psoriasis Results Presented
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Oct 08, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Otezla, Apremilast, Scalp Psoriasis